Sam Lee - Cocrystal Pharma Insider

COCP -- USA Stock  

USD 4.81  0.06  1.23%

Co-Founder and Pres
Dr. Sam Lee is the President of Cocrystal Pharma, Inc. Dr. Lee has served as President of Cocrystal since January 2, 2014. From January 2, 2014 until November 22, 2014, He was a director of Cocrystal. He is a cofounder of Cocrystal Discovery and was President and a director of Cocrystal Discovery since 2007. He has 17 years of antiinfective drug discovery research experience. Prior to being a cofounder of Cocrystal, he managed antiinfective, oncology, and inflammation drug discovery projects for eight years at ICOS Corporationrationration
Age: 55  Founder Since 2014  Ph.D    
678-892-8800  http://www.cocrystalpharma.com
Lee was responsible for incorporating protein crystallography and structural biology approaches into ICOS research. He received his Ph.D. in Biological Sciences from the University of Notre Dame, and completed postdoctoral training in viral replication biochemistry with Dr. I. R. Lehman at Stanford University. While at Stanford, Dr. Lee founded and was CEO of Viral Assays in Cupertino, CA.

Management Efficiency

The company has return on total asset (ROA) of (3.7) % which means that it has lost $3.7 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 0.37 % meaning that it created $0.37 on every $100 dollars invested by stockholders.
The company currently holds 2.04 M in liabilities with Debt to Equity (D/E) ratio of 1.9 which is about average as compared to similar companies. Cocrystal Pharma has Current Ratio of 1.07 suggesting that it is in a questionable position to pay out its financial obligations when they are due.

Entity Summary

Cocrystal Pharma, Inc., a clinical stage biotechnology company, engages in discovering and developing various novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal Pharma, Inc. was founded in 2007 and is headquartered in Tucker, Georgia. Cocrystal Pharma operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 10 people.Cocrystal Pharma (COCP) is traded on OTC Market in USA. It is located in 1860 Montreal Road and employs 10 people.

Cocrystal Pharma Leadership Team

Sam Lee, Founder, Ph.D
Raymond Schinazi, Director, CFA
Gary Wilcox, Chairman, Ph.D
James Martin, CFO
Jeffrey Meckler, CEO
Curtis Dale, CFO
Steven Rubin, Director
Phillip Frost, Director
David Block, Director
Douglas Mayers, Executive
Walt Linscott, Director
Jane Hsiao, Director, Ph.D

Stock Performance Indicators

Did you try this?

Run Volatility Analysis Now
   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Volatility Analysis

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Cocrystal Pharma and Novartis AG. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">